Opinions expressed by Digital Journal contributors are their own.
In the ever-evolving landscape of pharmaceuticals, innovation is not just desirable; it’s essential. By their very nature, medicine and pharmaceuticals inherently need to evolve in tandem with the community and individuals they serve. If they don’t, countless lives could be lost.
The COVID-19 pandemic was a perfect example of this: were it not for brave innovators in the field, the vaccines would not have been created as quickly as they were, and thousands more lives could have been lost.
One such pharmaceutical innovator is Ojas Prakashbhai Doshi. He is currently working as a Product Development Scientist at Cosette Pharmaceuticals Inc., where he is pioneering advancements in multiple dosage forms and drug delivery systems. Ojas is on the frontlines of innovation and advancement. His role and contributions within the pharmaceutical industry are vast and varied, focusing on innovation and developing advanced drug formulations.
Ojas’s work spans various pharmaceutical products, including Ophthalmic, Parenteral, oral solutions, oral suspensions, suppositories, otic suspensions, topical creams, ointments, etc. He is also involved in both New Drug Applications (NDA) and Abbreviated New Drug Applications (ANDA), showcasing his versatility and comprehensive understanding of pharmaceutical development.
Ojas’s origin
From the time Ojas began his journey in the pharmaceutical industry, he has been driven by a deep-rooted commitment to innovation and a desire to improve healthcare outcomes. His tale is of dedication, perseverance, and a relentless pursuit of scientific advancement in drug development, particularly in Sterile dosage forms, which include ophthalmic and injectable therapies, Oral Solutions, and other diverse dosage forms.
From the earliest stages of his career, Ojas was captivated by the critical need for enhanced drug delivery systems, especially in combating eye diseases effectively. Witnessing the substantial financial and personal burdens on patients suffering from various conditions, Ojas was motivated to develop solutions to reduce treatment costs while improving efficacy and addressing drug resistance concerns.
Ojas surmises, “I was inspired to become involved in the pharmaceutical industry by a profound desire to make a tangible difference in people’s lives through scientific innovation. I have already made strides in this area and am committed to continuing this work.”
Innovative patents
Ojas’s innovative spirit is evident in his patent portfolio. He has secured five granted patents, alongside four that are currently pending. These patents focus on groundbreaking improvements in ocular drug delivery systems, particularly in formulations involving tobramycin, dexamethasone, and moxifloxacin with triamcinolone.
In Ojas’s words, “My work has significantly enhanced the efficacy and patient compliance of treatments for eye diseases, offering potential reductions in healthcare costs. One provisional patent application was filed recently, and the Oral liquid formulation method was disclosed. When this product is approved by the FDA and available to the public, it has the potential to be used by a large number of patients with dry mouth.”
Research contributions and publications
In the realm of research, Ojas has also co-authored nine high-impact research papers in collaboration with the Institute for Health Metrics and Evaluation, submitted to high-impact factors Lancet groups of journals. Furthermore, he has published ten articles in prestigious scientific journals, demonstrating his commitment to advancing pharmaceutical knowledge. His meticulous research and insights have been instrumental in shaping the direction and conclusions of these studies.
Professional role and leadership
As a Product Development Scientist at Cosette Pharmaceuticals Inc., Ojas leads a diverse portfolio of pharmaceutical projects. He serves as a Subject Matter Expert, collaborating with cross-functional teams to drive innovation and achieve remarkable scientific milestones.”
A vision for the brighter future
Looking forward, Ojas is ambitious about continuing to innovate within the pharmaceutical field and bringing easier, more affordable, and more accessible medical solutions to countless individuals struggling around the globe.
To do this, Ojas intends to continue capitalizing upon his unique interdisciplinary skills. “One of the most important lessons I’ve learned is the power of interdisciplinary thinking. In pharmaceutical development, breakthroughs often occur at the intersection of different fields. This cross-pollination of ideas can lead to innovative solutions and unique approaches to problem-solving.” As the pharmaceutical industry continues to evolve, innovators like Ojas will undoubtedly play a crucial role in shaping its future.
